0001144204-16-076474.txt : 20160121 0001144204-16-076474.hdr.sgml : 20160121 20160121144420 ACCESSION NUMBER: 0001144204-16-076474 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160119 FILED AS OF DATE: 20160121 DATE AS OF CHANGE: 20160121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000895051 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581959440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-864-2600 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DR STREET 2: STE 300 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ENTREMED INC DATE OF NAME CHANGE: 19960415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ren Ken CENTRAL INDEX KEY: 0001490733 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20713 FILM NUMBER: 161353284 MAIL ADDRESS: STREET 1: 3RD FL, BOROUGH A, BLOCK A STREET 2: NO. 181 SOUTH TAIBAI ROAD CITY: XI'AN, SHAANXI PROVINCE STATE: F4 ZIP: 710065 4 1 v429400_4.xml OWNERSHIP DOCUMENT X0306 4 2016-01-19 0 0000895051 CASI Pharmaceuticals, Inc. CASI 0001490733 Ren Ken CASI PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE, SUITE 300 ROCKVILLE MD 20850 1 1 0 0 CEO and Director Common Stock 2016-01-19 4 P 0 7537 0.73 A 7537 D Common Stock 2016-01-19 4 P 0 1100 0.74 A 8637 D Common Stock 2016-01-19 4 P 0 6063 0.72 A 14700 D Common Stock 2016-01-19 4 P 0 300 0.71 A 15000 D /s/ Ken K. Ren, Chief Executive Officer and Director 2016-01-21